MK0686 in Postsurgery Dental Pain (0686-002)

Phase 2

Completed

• Conditions: Pain, Postoperative

• Registration Number: NCT00533403
• Lead Sponsor: Merck Sharp & Dohme LLC

Brief Summary

To compare the pain relieving effect of MK0686 to placebo or ibuprofen after dental surgery.

Detailed Description

Not available

Basic Information
|
Recruitment & Eligibility
|
Study & Design

Study Timeline

• Study Start: 2004-07
• Primary Completion: 2004-11
• Study Completion: 2004-11
• Study First Submitted: 2007-09-19
• Study First Submitted QC: 2007-09-19
• Study First Posted: 2007-09-21
• Status Verified: 2015-06
• Last Update Submitted: 2015-06-25
• Last Update Posted: 2015-06-26

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 114

Inclusion Criteria

• Men and women ages 18-45 years who are scheduled to have 2 or more third molars (wisdom teeth) removed
• Patients must agree to remain in the clinic for 24 hours after surgery

Read More

Exclusion Criteria

• Patient has history of heart disease, asthma, pulmonary disease
• Patient must discontinue use of certain pain medicines 24-72 hours prior to the surgery

Read More

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: PARALLEL